EUVIMEDEUVIMED entdecken
Crossref

Oncological characteristics of epidermal growth factor receptor–mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance

Aritoshi Hattori, Takeshi Matsunaga, Mariko Fukui, Hisashi Tomita, Kazuya Takamochi, Kenji Suzuki

The Journal of Thoracic and Cardiovascular Surgery · 2024-09 · 168 (3) · 685-696.e2

DOI: 10.1016/j.jtcvs.2023.11.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024-09. Verfasst von Aritoshi Hattori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: ahattori@juntendo.ac.jp. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, ErbB Receptors, Lung Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Cancer Center Japan, Juntendo University, Japan Labour Health and Welfare Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We evaluated the clinicopathological and oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA radiological pure-solid lung adenocarcinoma and compared them with those of a ground-glass opacity component. METHODS: Between 2008 and 2020, data from 1014 surgically resected clinical stage 0-IA epidermal growth factor receptor-mutated lung adenocarcinomas were evaluated. Oncological outcomes were assessed using multivariable analysis. Overall survival was estimated using Kaplan-Meier analysis and the log-rank test. The cumulative incidence of recurrence was estimated using the Gray's test. RESULTS: Of these, 233 (23%) were radiologically pure-solid tumors, which demonstrated a higher proportion of nodal metastasis, micropapillary component, spread through alveolar space, and Ex19 subtype compared with those of tumors with ground-glass opacity (P < .001). Multivariable analysis revealed that the presence of ground-glass opacity was an independently significant factor for overall survival (P = .037) and cumulative incidence of recurrence (P < .001). In cases where the oncological outcomes were stratified by the presence of ground-glass opacity component, the 5-year overall survival was excellent at more than 90% in tumors with ground-glass opacity despite clinical-T categories (P = .2044); however, tumor size significantly affected survival only in pure-solid tumors (T1a, 100%; T1b, 77.7%; T1c, 68.5%; P = .0056). Furthermore, the cumulative incidence of recurrence was low in tumors with ground-glass opacity despite the clinical-T categories, whereas tumor size significantly affected the cumulative incidence of recurrence only in pure-solid tumors (5-year cumulative incidence of recurrence: T1a-b, 18.9%; T1c, 41.3%; P < .001). CONCLUSIONS: Oncologic behavior and prognosis of radiologically pure-solid tumors were significantly poorer than those of tumors with ground-glass opacity among patients with epidermal growth factor receptor-mutated early-stage lung adenocarcinoma. These findings imply distinct tumorigenesis based on the presence of ground-glass opacity, even in tumors with epidermal growth factor receptor mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungErbB ReceptorsLung NeoplasmsNeoplasm StagingMutationHumansMaleFemaleAgedMiddle AgedRetrospective StudiesNeoplasm Recurrence, LocalPneumonectomyTomography, X-Ray Computed

Stichwörter der Autor:innen

epidermal growth factor receptorground-glass opacitylung adenocarcinoma

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: ahattori@juntendo.ac.jp.
  • Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Förderung

  • National Cancer Center Japan
  • Juntendo University
  • Japan Labour Health and Welfare Organization
  • National Cancer Center
  • Ministry of Health, Labour and Welfare
  • Smoking Research Foundation

Zitieren

APA

Hattori, A., Matsunaga, T., Fukui, M., Tomita, H., Takamochi, K., & Suzuki, K. (2024). Oncological characteristics of epidermal growth factor receptor–mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance. The Journal of Thoracic and Cardiovascular Surgery, 168(3), 685-696.e2. https://doi.org/10.1016/j.jtcvs.2023.11.025

Vancouver

Hattori A, Matsunaga T, Fukui M, Tomita H, Takamochi K, Suzuki K. Oncological characteristics of epidermal growth factor receptor–mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance. The Journal of Thoracic and Cardiovascular Surgery. 2024;168(3):685-696.e2. doi:10.1016/j.jtcvs.2023.11.025

BibTeX
@article{Hattori2024,
  author = {Hattori, Aritoshi and Matsunaga, Takeshi and Fukui, Mariko and Tomita, Hisashi and Takamochi, Kazuya and Suzuki, Kenji},
  title = {Oncological characteristics of epidermal growth factor receptor–mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  volume = {168},
  number = {3},
  pages = {685--696.e2},
  doi = {10.1016/j.jtcvs.2023.11.025}
}
Kostenlos starten →